ProfhEX: AI-based platform for small molecules liability profiling
暂无分享,去创建一个
[1] E. Muratov,et al. MolPredictX: Online Biological Activity Predictions by Machine Learning Models , 2022, Molecular informatics.
[2] Daniel M. Wilson,et al. Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches. , 2022, Computational toxicology.
[3] Christopher M. Grulke,et al. The effect of noise on the predictive limit of QSAR models , 2021, Journal of Cheminformatics.
[4] M. Salem,et al. MolData, a molecular benchmark for disease and target based machine learning , 2021, Journal of Cheminformatics.
[5] Daniel P. Russo,et al. In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities. , 2021, Computational toxicology.
[6] F. Cedrón,et al. A review on machine learning approaches and trends in drug discovery , 2021, Computational and structural biotechnology journal.
[7] K. Héberger,et al. Machine learning models for classification tasks related to drug safety , 2021, Molecular Diversity.
[8] Pravir Kumar,et al. Artificial intelligence to deep learning: machine intelligence approach for drug discovery , 2021, Molecular Diversity.
[9] A. Beccari,et al. “Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool , 2021, Journal of Cheminformatics.
[10] Sezen Vatansever,et al. Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions , 2020, Medicinal research reviews.
[11] Peter B. McGarvey,et al. UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..
[12] Benjamin A. Shoemaker,et al. PubChem in 2021: new data content and improved web interfaces , 2020, Nucleic Acids Res..
[13] Chaoyang Zhang,et al. Structure–activity relationship-based chemical classification of highly imbalanced Tox21 datasets , 2020, Journal of Cheminformatics.
[14] Prachi Pradeep,et al. Variability in in vivo studies: Defining the upper limit of performance for predictions of systemic effect levels. , 2020, Computational toxicology.
[15] Linlin Zhao,et al. Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling. , 2020, Drug discovery today.
[16] Daniel Svozil,et al. QSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction , 2020, Journal of Cheminformatics.
[17] D. Mendrick,et al. An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). , 2020, Regulatory toxicology and pharmacology : RTP.
[18] David Schaller,et al. Next generation 3D pharmacophore modeling , 2020, WIREs Computational Molecular Science.
[19] Ruili Huang,et al. CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity , 2020, Environmental health perspectives.
[20] Terry R Van Vleet,et al. An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation. , 2020, Chemical research in toxicology.
[21] Leela Sarath Kumar Konda,et al. hERG liability classification models using machine learning techniques , 2019, Computational Toxicology.
[22] Fredrik Svensson,et al. LightGBM: An Effective and Scalable Algorithm for Prediction of Chemical Toxicity-Application to the Tox21 and Mutagenicity Data Sets , 2019, J. Chem. Inf. Model..
[23] Xin Huang,et al. Novel Computational Approach to Predict Off-Target Interactions for Small Molecules , 2019, Front. Big Data.
[24] Andreas Bender,et al. Leveraging heterogeneous data from GHS toxicity annotations, molecular and protein target descriptors and Tox21 assay readouts to predict and rationalise acute toxicity , 2019, Journal of Cheminformatics.
[25] Friedrich Rippmann,et al. Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting , 2019, Journal of Cheminformatics.
[26] Andrew R. Leach,et al. Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery , 2019, Journal of Cheminformatics.
[27] Andrew R. Leach,et al. ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..
[28] Jean-Louis Reymond,et al. Polypharmacology Browser PPB2: Target Prediction Combining Nearest Neighbors with Machine Learning , 2018, J. Chem. Inf. Model..
[29] Ewgenij Proschak,et al. Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds. , 2018, Journal of medicinal chemistry.
[30] Hugo Ceulemans,et al. Large-scale comparison of machine learning methods for drug target prediction on ChEMBL† †Electronic supplementary information (ESI) available: Overview, Data Collection and Clustering, Methods, Results, Appendix. See DOI: 10.1039/c8sc00148k , 2018, Chemical science.
[31] Dongsup Kim,et al. Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server , 2017, BMC Bioinformatics.
[32] Minho Lee,et al. Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server , 2017, BMC Bioinformatics.
[33] R. Judson,et al. Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates , 2017, Archives of Toxicology.
[34] E. Blomme,et al. Potential functional and pathological side effects related to off-target pharmacological activity. , 2017, Journal of pharmacological and toxicological methods.
[35] George Papadatos,et al. Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set , 2017, bioRxiv.
[36] R. Vickery,et al. Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists. , 2017, Bioorganic & medicinal chemistry letters.
[37] Shuxing Zhang,et al. Polypharmacology in Drug Development: A Minireview of Current Technologies , 2016, ChemMedChem.
[38] Jie Dong,et al. TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models , 2016, Journal of Computer-Aided Molecular Design.
[39] Ruili Huang,et al. CERAPP: Collaborative Estrogen Receptor Activity Prediction Project , 2016, Environmental health perspectives.
[40] Robert Preissner,et al. WITHDRAWN—a resource for withdrawn and discontinued drugs , 2015, Nucleic Acids Res..
[41] Andreas Bender,et al. Target prediction utilising negative bioactivity data covering large chemical space , 2015, Journal of Cheminformatics.
[42] Luca Pinzi,et al. Computational polypharmacology comes of age , 2015, Front. Pharmacol..
[43] V. Setola,et al. Further evaluation of the tropane analogs of haloperidol. , 2014, Bioorganic & medicinal chemistry letters.
[44] J. Bajorath,et al. Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.
[45] Jean-Louis Reymond,et al. Expanding the fragrance chemical space for virtual screening , 2014, Journal of Cheminformatics.
[46] M. Pangalos,et al. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework , 2014, Nature Reviews Drug Discovery.
[47] P. M. Thompson,et al. Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase. , 2014, Bioorganic & Medicinal Chemistry Letters.
[48] Andreas Bender,et al. In Silico Target Predictions: Defining a Benchmarking Data Set and Comparison of Performance of the Multiclass Naïve Bayes and Parzen-Rosenblatt Window , 2013, J. Chem. Inf. Model..
[49] Lirong Wang,et al. TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database , 2013, The AAPS Journal.
[50] Gareth J Waldron,et al. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling , 2012, Nature Reviews Drug Discovery.
[51] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.
[52] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[53] Roberto Todeschini,et al. Comparison of Different Approaches to Define the Applicability Domain of QSAR Models , 2012, Molecules.
[54] Pekka Tiikkainen,et al. Computational tools for polypharmacology and repurposing. , 2011, Future medicinal chemistry.
[55] Rainer E. Martin,et al. Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists. , 2010, Bioorganic & medicinal chemistry letters.
[56] Alexander Tropsha,et al. Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..
[57] Sheng-Yong Yang,et al. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.
[58] Thorsten Meinl,et al. KNIME - the Konstanz information miner: version 2.0 and beyond , 2009, SKDD.
[59] J. Goodier. The Concise Encyclopedia of Statistics , 2009 .
[60] Paolo Mazzatorta,et al. Modeling Oral Rat Chronic Toxicity , 2008, J. Chem. Inf. Model..
[61] Jean-Louis Reymond,et al. Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry, Physicochemical Properties, Compound Classes, and Drug Discovery , 2007, J. Chem. Inf. Model..
[62] M. Ivanovic,et al. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor. , 2006, Bioorganic & medicinal chemistry.
[63] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[64] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[65] J. Friedman. Greedy function approximation: A gradient boosting machine. , 2001 .
[66] Dan Boneh,et al. On genetic algorithms , 1995, COLT '95.
[67] James E. Campbell,et al. An Approach to Sensitivity Analysis of Computer Models: Part I—Introduction, Input Variable Selection and Preliminary Variable Assessment , 1981 .
[68] Anton Simeonov,et al. The US Federal Tox21 Program: A strategic and operational plan for continued leadership. , 2018, ALTEX.
[69] Derek S. Tan,et al. Principal component analysis as a tool for library design: a case study investigating natural products, brand-name drugs, natural product-like libraries, and drug-like libraries. , 2015, Methods in molecular biology.
[70] Paola Gramatica,et al. On the development and validation of QSAR models. , 2013, Methods in molecular biology.
[71] D. Dix,et al. The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[72] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[73] V. Claassen. Neglected factors in pharmacology and neuroscience research , 1994 .